APA

Montano G., Ullmark T., Jernmark-Nilsson H., Sodaro G., Drott K., Costanzo P., Vidovic K. & Gullberg U. (20160511). The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein. : Leukemia research.

Chicago

Montano Giorgia, Ullmark Tove, Jernmark-Nilsson Helena, Sodaro Gaetano, Drott Kristina, Costanzo Paola, Vidovic Karina and Gullberg Urban. 20160511. The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein. : Leukemia research.

Harvard

Montano G., Ullmark T., Jernmark-Nilsson H., Sodaro G., Drott K., Costanzo P., Vidovic K. and Gullberg U. (20160511). The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein. : Leukemia research.

MLA

Montano Giorgia, Ullmark Tove, Jernmark-Nilsson Helena, Sodaro Gaetano, Drott Kristina, Costanzo Paola, Vidovic Karina and Gullberg Urban. The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein. : Leukemia research. 20160511.